The trajectory of Sildenafil presents a challenging picture for those considering investment. While the initial release generated massive profits, the lapse of its patent opened the floodgates to generic competitors, https://single-bookmark.com/story21652022/the-copyright-and-big-pharma-a-volatile-bet